OEM
Anesthesia and Pain Management
Electronic Stimulator
2001-0264
HUAXING
17x8.5x4.8 cm
China Jiangsu
Product Description
Health Medical Ultrasonic Stimulator - Nerve Block Plexus Needle Stimulator
| Place of Origin | China Jiangsu |
| Brand Name | HUAXING |
| Model Number | OEM |
| Disinfecting Type | EOS |
| Properties | Medical Adhesive & Suture Material |
| Size | 17x8.5x4.8 cm |
| Stock | Yes |
| Shelf Life | 3 years |
| Material | PC |
| Quality Certification | ce |
| Instrument classification | Class II |
| Safety standard | ISO 13485 |
| Product Name | nerve block plexus needle stimulator |
| Usage | Anesthesia and pain management |
| Type | electronic stimulator |
| Licence Number | 2001-0264 |
Founded in 1999, Hua Xing boasts a registered capital of $7.5 million. Spanning an impressive 25,000 square meters, our factory is home to 200 skilled workers.
With 50 dedicated administrative staff, we are proud to operate ISO levels 8, 7, and 5 clean rooms, all meticulously designed to meet GMP and ISO standards.
These standards ensure unparalleled quality and safety. Our diverse product range includes anesthesia products, gynecology instruments, surgical tools,
ICU and CT devices. Hua Xing has secured CFDA certification for 40 products, and our brand is recognized as a renowned trademark.
To maintain our unwavering commitment to quality, we've invested $450,000 in a state-of-the-art testing center equipped with all necessary testing apparatus. Our QC staff are CFDA-certified, ensuring rigorous quality control from raw materials to final inspection. Our dedication to quality is validated by passing GMP and ISO 13485 inspections, with select products achieving CE certification from TUV Rheinland. Our products are sold and exported internationally. Our team includes 30 highly skilled administrative staff and 20 technical experts, driving continuous innovation. Annually, we invest $400,000 in R&D to stay ahead in a competitive market. To date, we hold 48 patents. Our products are acclaimed for their superior quality in the market and hospitals. Moving forward, we remain committed to enhancing product visibility, maintaining our brand image, and fostering continuous innovation.
